Journal article

Economic evaluation of a phase III international randomised controlled trial of very early mobilisation after stroke (AVERT)

Lan Gao, Lauren Sheppard, Olivia Wu, Leonid Churilov, Mohammadreza Mohebbi, Janice Collier, Julie Bernhardt, Fiona Ellery, Helen Dewey, Marj Moodie

BMJ Open | BMJ PUBLISHING GROUP | Published : 2019

Grants

Awarded by National Health and Medical Research Council (NHMRC) of Australia


Awarded by Singapore Health


Awarded by Chest Heart and Stroke Scotland


Awarded by Stroke Association UK


Awarded by NHMRC


Awarded by Australia Research Council Future Fellowship


Funding Acknowledgements

The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The economic evaluation component of the AVERT study was funded by the National Health and Medical Research Council (NHMRC) of Australia (grant numbers 386201 and 1041401). Additional funding was received from Singapore Health (SHF/FG401P/2008), Chest Heart and Stroke Scotland (Res08/A114), Northern Ireland Chest Heart and Stroke and the Stroke Association UK (TSA2009/09). NHMRC fellowship funding was provided to HD (336102) and JB (1058635). JB was also supported by an Australia Research Council Future Fellowship (IFT0991086) and the National Heart Foundation. The Florey Institute of Neuroscience and Mental Health acknowledges the support received from the Victorian Government via the Operational Infrastructure Support Scheme. The content of the publication is solely the responsibility of the authors and does not reflect the views of the funders.